European Monitoring Centre for Drugs and Drug Addiction. (2010). Treatment and care for older drug users (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: ’Drug problems have no age limits’ – This special review published alongside the 2010 Annual report, reveals why drug use is no longer simply a ‘youth phenomenon’. Europe is experiencing a pronounced ageing of its population, around a quarter of which will be aged 65 or over by 2050. Statistics published today show that Europe’s drug-using population is also ageing and that meeting the needs of older drug users is a growing issue for treatment services. This is particularly the case in western countries which saw the EU’s first heroin epidemics in the 1980s and 1990s.
Keywords: target group; elderly; old age; drug user; addiction; AOD use, abuse, and dependence; chemical addiction; demographic change; treatment and maintenance; health care delivery; Europe
|
European Monitoring Centre for Drugs and Drug Addiction. (2010). Problem amphetamine and methamphetamine use in Europe (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: Focusing on European countries where amphetamine or methamphetamine is an important part of the drug problem, this Selected issue looks at the current situation in the light of the historical development of amphetamines use since the introduction of these substances as medicines in the 1930s. The history of amphetamines use is the result of an interplay of global forces, such as the spread of recreational drug use in the 1960s and the arrival of heroin on the European drug scene in the 1970s, and local events such as the rise of small-scale pervitin (methamphetamine) production in what was then Czechoslovakia. The outcome of this is that, in the present day, problem amphetamines use across Europe is marked by strong national characteristics, possibly more so than any other of the major illicit drugs.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; amphetamines; methamphetamines; history; drug trafficking; AOD supply; other drug laws; AOD effects and consequences; Europe
|
Montanari, L., Guarita, B., Noor, A., Wiessing, L., Gomes, F., Hedrich, D., et al. (2012). Treatment demand indicator (TDI) : standard protocol 3.0 : guidelines for reporting data on people entering drug treatment in European countries (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 9. Luxembourg: Publications Office of the European Union.
Abstract: This Manual is a revised edition of the Treatment demand indicator (TDI) protocol version 2.0 and presents updated guidelines for reporting data on people entering drug treatment in Europe. The TDI is one of five key epidemiological indicators which provide a common European methodology for collecting and reporting core data on the number and profiles of those entering specialised drug treatment each year. TDI data are routinely used in EMCDDA analysis of the drug situation in Europe, helping to identify trends and patterns in problem drug use and to assess the use and uptake of treatment facilities.
Keywords: addiction; harm reduction; treatment and maintenance; heroin-assisted treatment; methadone; quality control; recommendations or guidelines; database; international area; Europe; report
|
Robertson, K. (2010). Harm reduction moves to the mainstream : EU drugs agency publishes major work on harm reduction: past, present and future (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Keywords: harm reduction; history; cooperation; research; drug user; public policy on illicit drugs; international area; Europe; press release
|
Robertson, K. (2010). New drug placed under official scrutiny across Europe : council calls on EU scientific experts to assess risks of mephedrone (European Monitoring Centre for Drugs and Drug Addiction, Ed.). News release from the EU drugs agency in Lisbon. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Abstract: Europe has responded to rising concern over the use of the synthetic drug mephedrone by formally requesting a scientific investigation into the health and social risks of the substance. The decision was communicated to the EU drugs agency (EMCDDA) by the Council of the EU today, in line with a legal procedure designed to respond to potentially threatening new psychoactive drugs in the EU.
Keywords: cooperation; risk assessment; addiction; chemical addiction; AOD dependence; other AOD substances; mephedrone; research in general; internet; legal regulation; Europe; press release
|
Olszewski, D., Hedrich, D., Montanari, L., & European Monitoring Centre for Drugs and Drug Addiction. (2012). Users' voices : experiences and perceptions of European drug users on controlling their drug consumption (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Thematic papers. Luxembourg: Publications Office of the European Union.
Abstract: A collection of narratives from substance users in Europe about their attempts to control or reduce their consumption is released today by the EMCDDA. Entitled Users’ voices, the paper illustrates how qualitative research can provide glimpses into the experiences and perceptions of substance users that statistics alone cannot provide.Organization in 1986 (WHO, 1986). Quotations, gleaned from interviews with substance users in Europe, help to focus on their total needs by providing glimpses into the different ways individuals attempt to control or reduce their consumption of drugs or alcohol. This paper does not attempt to assess the relative efficacy of any specific drug or alcohol approach or intervention: its purpose is to highlight the fact that there is enormous heterogeneity in different individual experiences and the quotations used give voice to some of these very different experiences. In this way, quotations provide important insights and meaning into the figures on prevalence of drug use and treatment statistics.
Keywords: addiction; drug user; monitoring; treatment and maintenance; individual differences; international differences; international area; Europe
|
Europäische Union. (2005). Informationsaustausch, Risikobewertung und Kontrolle bei neuen psychoaktiven Substanzen (Europäische Union, Ed.). Brüssel: Europäische Union.
Abstract: Mit diesem Beschluss wird ein System zum raschen Austausch von Informationen über die neuen psychoaktiven Substanzen, eine Risikobewertung durch einen wissenschaftlichen Ausschuss und ein europäisches Verfahren zur Einführung von Kontrollmaßnahmen für die gemeldeten Substanzen eingeführt. Er hebt die Gemeinsame Maßnahme betreffend neue synthetische Drogen von 1997 auf.
Keywords: government and politics; legal regulation; addiction; chemical addiction; AOD dependence; designer drug; research chemical; cooperation; risk assessment; Europe
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2007). Jahresbericht 2007 : Stand der Drogenproblematik in Europa (Europäische Beobachtungsstelle für Drogen und Drogensucht, Ed.). Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2008). Jahresbericht 2008 : Stand der Drogenproblematik in Europa (Europäische Beobachtungsstelle für Drogen und Drogensucht, Ed.). Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; gamma-hydroxybutyric acid; gamma-butyrolactone; communicable disease; AODR mortality; Europe; annual report
|
Robertson, K. (2010). Schadensminderung etabliert sich : EU-Drogenbeobachtungsstelle veröffentlicht markantes Werk zur Schadensminderung: Vergangenheit, Gegenwart und Zukunft (Europäische Beobachtungsstelle für Drogen und Drogensucht, Ed.). Lissabon: Europäische Beobachtungsstelle für Drogen und Drogensucht (EBDD).
Keywords: harm reduction; history; cooperation; research; drug user; public policy on illicit drugs; international area; Europe; press release
|